A cholesterol secret inside ticks may halt Lyme disease spread Scientists have discovered that the bacteria behind Lyme disease and anaplasmosis have a sneaky way of surviving inside ticks—they hijack the tick’s own cell functions to steal cholesterol they need to grow. By tapping into a built-in protein pathway, the bacteria keep themselves alive until they can infect a new host. The research opens the door to new methods of stopping these diseases before ticks ever get the chance to bite. A new web tool also reveals that this trick might be used by other blood-feeding bugs too.
https://www.sciencedaily.com/r....eleases/2025/07/2507

The surprising link between hearing loss, loneliness, and lifespan People who treat hearing loss with hearing aids or cochlear implants regain rich conversations, escape isolation, and may even protect their brains and lifespans—proof that better hearing translates into fuller living.
https://www.sciencedaily.com/r....eleases/2025/07/2507

Parkinson’s reversal? One drug brings dying brain cells back to life Stanford researchers discovered that dialing down an overactive enzyme, LRRK2, can regrow lost cellular “antennae” in key brain cells, restoring vital dopamine communication and neuroprotective signals in a mouse model of genetic Parkinson’s. After three months on the LRRK2-blocking drug MLi-2, damaged circuits revived and early signs of neuronal recovery emerged, hinting that timely treatment could not only halt but reverse disease progression—and perhaps benefit other Parkinson’s forms.
https://www.sciencedaily.com/r....eleases/2025/07/2507

Magnesium Deficiency in IBD Patients and the Role of Natural Support When you’re living with a chronic illness like Crohn’s disease or ulcerative colitis, it’s easy to become hyper-aware of every medication, every symptom, and every nutrient—or lack thereof. One essential mineral that often flies under the radar is magnesium. Magnesium supports nerve function, hormone balance and how we respond to stress, so when levels drop, …
https://lightscameracrohns.com..../2025/07/02/magnesiu

Is that really ADHD? Why flawed trials may be misleading millions Researchers reviewing nearly 300 top-tier ADHD drug trials found that half skipped the rigorous, expert-led evaluations needed to rule out other conditions like depression or schizophrenia. With diagnoses often made by unqualified staff—or even by computer—many participants may not have actually had ADHD, casting doubt on study outcomes that shape treatment guidelines.
https://www.sciencedaily.com/r....eleases/2025/07/2507